|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Encounter for adjustment or removal of breast implant
ICD-10 (CM) Code and Descriptor
|
Z45.811 |
Encounter for adjustment or removal of right breast implant
|
Z45811 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 52.67%
|
28.93%
|
6.93%
|
4.13%
|
3.87%
|
0.40%
|
0.40%
|
0.67%
|
0.93%
|
0.53%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z45.811*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J3010
|
FENTANYL CITRATE INJECTION |
238
|
460
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
232
|
9,571
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
228
|
917
|
|
J2405
|
ONDANSETRON HCL INJECTION |
208
|
913
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
177
|
1,206
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
170
|
864
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
147
|
296
|
|
C1789
|
PROSTHESIS, BREAST, IMP |
129
|
199
|
|
88300
|
SURGICAL PATH GROSS |
107
|
131
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
101
|
699
|
|
11970
|
RPLCMT TISS XPNDR PERM IMPLT |
92
|
92
|
|
J1170
|
HYDROMORPHONE INJECTION |
91
|
167
|
|
J1580
|
GARAMYCIN GENTAMICIN INJ |
89
|
138
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
88
|
88
|
|
J2001
|
LIDOCAINE INJECTION |
86
|
1,321
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
82
|
103
|
|
J7120
|
RINGERS LACTATE INFUSION |
81
|
105
|
|
J2370
|
PHENYLEPHRINE HCL INJECTION |
69
|
222
|
|
19342
|
INSJ/RPLCMT BRST IMPLT SEP D |
67
|
67
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
53
|
71
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z45.811 related to the following DRG Codes:
951
|
